Correlation Between Biomea Fusion and Halozyme Therapeutics
Can any of the company-specific risk be diversified away by investing in both Biomea Fusion and Halozyme Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biomea Fusion and Halozyme Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biomea Fusion and Halozyme Therapeutics, you can compare the effects of market volatilities on Biomea Fusion and Halozyme Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biomea Fusion with a short position of Halozyme Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biomea Fusion and Halozyme Therapeutics.
Diversification Opportunities for Biomea Fusion and Halozyme Therapeutics
-0.4 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Biomea and Halozyme is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Biomea Fusion and Halozyme Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Halozyme Therapeutics and Biomea Fusion is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biomea Fusion are associated (or correlated) with Halozyme Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Halozyme Therapeutics has no effect on the direction of Biomea Fusion i.e., Biomea Fusion and Halozyme Therapeutics go up and down completely randomly.
Pair Corralation between Biomea Fusion and Halozyme Therapeutics
Given the investment horizon of 90 days Biomea Fusion is expected to under-perform the Halozyme Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Biomea Fusion is 1.1 times less risky than Halozyme Therapeutics. The stock trades about -0.51 of its potential returns per unit of risk. The Halozyme Therapeutics is currently generating about -0.06 of returns per unit of risk over similar time horizon. If you would invest 5,080 in Halozyme Therapeutics on August 24, 2024 and sell it today you would lose (510.00) from holding Halozyme Therapeutics or give up 10.04% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Biomea Fusion vs. Halozyme Therapeutics
Performance |
| Timeline |
| Biomea Fusion |
| Halozyme Therapeutics |
Biomea Fusion and Halozyme Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biomea Fusion and Halozyme Therapeutics
The main advantage of trading using opposite Biomea Fusion and Halozyme Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biomea Fusion position performs unexpectedly, Halozyme Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Halozyme Therapeutics will offset losses from the drop in Halozyme Therapeutics' long position.| Biomea Fusion vs. ZyVersa Therapeutics | Biomea Fusion vs. Sonnet Biotherapeutics Holdings | Biomea Fusion vs. Zura Bio Limited | Biomea Fusion vs. Phio Pharmaceuticals Corp |
| Halozyme Therapeutics vs. Agios Pharm | Halozyme Therapeutics vs. Insmed Inc | Halozyme Therapeutics vs. Ultragenyx | Halozyme Therapeutics vs. Biomarin Pharmaceutical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |